Retatrutide vs Mounjaro vs Wegovy: The Next Generation of Weight-Loss Medicine

Three names dominate weight-loss medicine right now: Wegovy, Mounjaro, and the newcomer everyone is watching, retatrutide. They are not the same, and the differences in how they work, how much weight they shift, and crucially how safely you obtain them, matter a great deal.

How they actually differ

The science is genuinely a story of generations:

• Wegovy (semaglutide) acts on a single hormone pathway, GLP-1. It was the first to bring dramatic medical weight loss to the mainstream.
• Mounjaro (tirzepatide) acts on two, GIP and GLP-1. Two levers, broadly, more effect.
• Retatrutide acts on three, GIP, GLP-1 and glucagon. It is a first-in-class triple agonist, and it is still investigational.

Mounjaro vs Wegovy: what the head-to-head shows

Both work. But in a large real-world comparison of around 18,400 matched adults (JAMA Internal Medicine, 2024), people taking tirzepatide were significantly more likely to reach meaningful weight loss than those on semaglutide: roughly 1.8 times as likely to lose 5% or more, 2.5 times for 10% or more, and 3.2 times for 15% or more. At one year, the difference in weight change favored tirzepatide by about 7 percentage points. In short, Mounjaro tends to deliver more than Wegovy, though both are effective.

Retatrutide: the new contender

Retatrutide is the one generating headlines, and the data explain why. In its Phase 3 TRIUMPH-1 trial (Eli Lilly, 2026), adults with obesity on the highest dose lost on average about 28% of their body weight, over 70 lbs, at 80 weeks, with many reaching reductions previously associated mainly with bariatric surgery. Important caveat: retatrutide is investigational and not yet approved. It is one to watch closely, not a treatment that can be prescribed today.

The part nobody advertises: the underground market

Because demand outstrips supply, and because retatrutide is not yet approved, a large grey market has grown around these compounds. They are sold online as "research chemicals" and self-injected with no medical oversight. The problem is simple and serious: unregulated product carries no guarantee of purity, dose accuracy or sterility. You do not truly know what is in the vial, how much, or whether it is contaminated.

Why pharmacy-grade, prescribed medicine is the only safe route

A patented, pharmacy-grade medicine is made to strict regulatory standards: verified purity, exact dosing, sterility and traceability. It is prescribed for your situation, dosed correctly, and monitored over time. An underground vial offers none of that. For something you inject into your body for months, a regulated medicine from a legitimate source, prescribed and monitored by a doctor, will always be the safer choice than an unregulated one. That is not a small detail. It is the whole point.

How we approach it

At Longevity Marbella, medical weight loss uses regulated, approved medicines, prescribed and monitored by a doctor double board-certified in Endocrinology and Hospital Medicine, and matched to you. As newer options such as retatrutide reach approval, an evidence-based clinic adopts them properly, never through the grey market.